Jason Wells Griffith, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 2 | 2023 | 1518 | 0.490 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2023 | 3077 | 0.480 |
Why?
|
| Propylene Glycols | 1 | 2013 | 91 | 0.420 |
Why?
|
| Sphingosine | 2 | 2022 | 307 | 0.410 |
Why?
|
| Plasmodium berghei | 2 | 2012 | 159 | 0.370 |
Why?
|
| Receptors, Chemokine | 1 | 2014 | 652 | 0.360 |
Why?
|
| Hemeproteins | 2 | 2009 | 61 | 0.350 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 575 | 0.350 |
Why?
|
| Chemokines | 1 | 2014 | 954 | 0.330 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2014 | 1798 | 0.310 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 584 | 0.300 |
Why?
|
| Immunity | 1 | 2014 | 994 | 0.290 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2024 | 254 | 0.290 |
Why?
|
| Malaria, Cerebral | 1 | 2007 | 136 | 0.260 |
Why?
|
| Malaria, Falciparum | 2 | 2012 | 1076 | 0.240 |
Why?
|
| Plasmodium falciparum | 2 | 2012 | 1740 | 0.220 |
Why?
|
| Uric Acid | 1 | 2009 | 807 | 0.220 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 299 | 0.200 |
Why?
|
| Allergens | 3 | 2020 | 1429 | 0.200 |
Why?
|
| Immunologic Memory | 3 | 2019 | 1355 | 0.190 |
Why?
|
| Lung | 6 | 2022 | 9998 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 505 | 0.170 |
Why?
|
| Immunomodulation | 2 | 2021 | 548 | 0.170 |
Why?
|
| Interleukin-1 | 1 | 2023 | 1248 | 0.170 |
Why?
|
| Peroxidases | 1 | 2019 | 134 | 0.160 |
Why?
|
| Immunity, Innate | 4 | 2023 | 3045 | 0.160 |
Why?
|
| Capillary Permeability | 1 | 2022 | 773 | 0.150 |
Why?
|
| Inflammation | 4 | 2016 | 10760 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3222 | 0.150 |
Why?
|
| Airway Remodeling | 1 | 2019 | 133 | 0.150 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 2 | 2008 | 108 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2019 | 274 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 445 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2009 | 4935 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 515 | 0.130 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 927 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2023 | 2604 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 10175 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1550 | 0.120 |
Why?
|
| Mice | 14 | 2024 | 81368 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3548 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 165 | 0.110 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 149 | 0.110 |
Why?
|
| Cell Migration Inhibition | 1 | 2013 | 97 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 87 | 0.110 |
Why?
|
| Respiratory System | 1 | 2016 | 563 | 0.110 |
Why?
|
| Cytokines | 6 | 2021 | 7373 | 0.110 |
Why?
|
| Pneumonia | 2 | 2019 | 2143 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1454 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2014 | 445 | 0.100 |
Why?
|
| Animals | 17 | 2024 | 168201 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1963 | 0.100 |
Why?
|
| Signal Transduction | 5 | 2021 | 23416 | 0.090 |
Why?
|
| Microscopy | 1 | 2016 | 905 | 0.090 |
Why?
|
| Th2 Cells | 1 | 2016 | 1056 | 0.090 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2008 | 105 | 0.090 |
Why?
|
| Asthma | 3 | 2019 | 6233 | 0.090 |
Why?
|
| Interferon-gamma | 2 | 2009 | 3145 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 101 | 0.080 |
Why?
|
| Interleukin-1alpha | 1 | 2009 | 86 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 724 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1409 | 0.080 |
Why?
|
| Macrophages | 3 | 2015 | 5758 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 2 | 2019 | 2916 | 0.080 |
Why?
|
| Structural Homology, Protein | 1 | 2008 | 87 | 0.080 |
Why?
|
| Immune System | 1 | 2014 | 791 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2722 | 0.080 |
Why?
|
| Leishmania major | 1 | 2008 | 59 | 0.080 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2009 | 159 | 0.080 |
Why?
|
| Allopurinol | 1 | 2009 | 198 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1788 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2012 | 6188 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 238 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2016 | 1167 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 1134 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 602 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.070 |
Why?
|
| Plasmodium chabaudi | 1 | 2006 | 19 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3088 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2009 | 696 | 0.070 |
Why?
|
| Cell Movement | 2 | 2019 | 5200 | 0.070 |
Why?
|
| Protozoan Proteins | 1 | 2012 | 846 | 0.070 |
Why?
|
| Contrast Media | 1 | 2019 | 5305 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4571 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2007 | 411 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 3688 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 9529 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 1336 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 998 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2007 | 1146 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2009 | 2481 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 22115 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3209 | 0.050 |
Why?
|
| Paroxetine | 1 | 2024 | 182 | 0.050 |
Why?
|
| Homeostasis | 1 | 2014 | 3321 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2152 | 0.050 |
Why?
|
| Erythropoiesis | 1 | 2006 | 684 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2812 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2007 | 911 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 764 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 494 | 0.050 |
Why?
|
| Integrin alphaV | 1 | 2019 | 54 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 4366 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1884 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3206 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2022 | 337 | 0.040 |
Why?
|
| Bronchial Provocation Tests | 1 | 2019 | 216 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4341 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 1202 | 0.040 |
Why?
|
| Humans | 14 | 2024 | 760617 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2021 | 458 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2013 | 4642 | 0.040 |
Why?
|
| Birefringence | 1 | 2016 | 54 | 0.030 |
Why?
|
| Epidermis | 1 | 2019 | 527 | 0.030 |
Why?
|
| Anemia | 1 | 2006 | 1504 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 2016 | 138 | 0.030 |
Why?
|
| Malaria | 1 | 2006 | 1226 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1154 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1865 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18221 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 428 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 153 | 0.030 |
Why?
|
| Virus Replication | 1 | 2003 | 2427 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 342 | 0.030 |
Why?
|
| Serotonin | 1 | 2019 | 1041 | 0.030 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14389 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2022 | 2661 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1683 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 340 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2019 | 909 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 806 | 0.030 |
Why?
|
| Leukocytes | 1 | 2020 | 2023 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36402 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 682 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1200 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3838 | 0.020 |
Why?
|
| Phenotype | 2 | 2022 | 16571 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2015 | 557 | 0.020 |
Why?
|
| Peptides | 1 | 2003 | 4354 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2447 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2015 | 18937 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5789 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3461 | 0.020 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2008 | 317 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11069 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 913 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2015 | 1350 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2115 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3419 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1404 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2006 | 212 | 0.020 |
Why?
|
| Shock | 1 | 2007 | 314 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 13441 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 1434 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 1880 | 0.010 |
Why?
|
| Antennapedia Homeodomain Protein | 1 | 2003 | 3 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 1989 | 0.010 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 11874 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 12116 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15828 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4058 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 17629 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1202 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1130 | 0.010 |
Why?
|
| Hindlimb | 1 | 2003 | 513 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 908 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2003 | 705 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 2202 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22148 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2178 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6520 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 1122 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 2112 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2007 | 2049 | 0.010 |
Why?
|
| Apoptosis | 1 | 2012 | 9476 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7237 | 0.010 |
Why?
|
| Male | 2 | 2019 | 360358 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4242 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1901 | 0.010 |
Why?
|
| Female | 2 | 2019 | 392148 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 6861 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3730 | 0.010 |
Why?
|
| Ischemia | 1 | 2003 | 1884 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15576 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 2413 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 220969 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11514 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4947 | 0.000 |
Why?
|